C
ell surface phenotype, cytotoxic specificity, and mode of activation are three important parameters that distingnish the major classes of human cytotoxic effector cells. For classic CTL, expression of the coreceptor molecules CD4 or CD8 governs the interaction with MHC class II or class I molecules, respectively. Triggering of the TC1L-ot[3-CD3 complex induces lysis that is specific for an MHC/ peptide ligand. In contrast, CD16+/CD56 + NK cells do not express TCR/CD3, CD4, or CD8 molecules, with the exception that some NK cells, defined as CD8 dim NK, display low amounts of CD8 (1) . NK cells do not show MHC-restricted target cell recognition, thus they recognize class l-negative target cells. Unlike CTL, no single receptor/ligand pair explaining NK target cell recognition has been identified. One positive signal for induction of NK cytotoxicity occurs through FclL~III (CD16) binding of antibody-coated target cells (2) . Interactions of CD2 with leukocytic function-associated-3 (CD58), and LFA-1 (CD 1 la) with intracellular adhesion molecule-1 (CD54), as well as CD27, have also been implicated in activation of NK lytic function (3, 4, reviewed in 5) . NK cells are maintained in a functional state that enables them to directly mediate cytotoxic potential, thus formation of target cell conjugates via a number of different ligand interactions may be sufficient to induce target cell destruction. Although expression of lytic potential in NK cells does not require presensitization, it can be enhanced by IL-2 and IL-12 (6) ; furthermore, stimulation with PHA or allogeneic cells can increase NK activity (7) . These modes of activation also induce cytolytic activity in some CD3 + T lymphocytes; these NK-like T cells are not MHC-restricted and they can lyse MHC class I-negative target cells such as Daudi and K562 (2, 8) ; for some ceils, an involvement of CD28 in activation is suggested (9) .
While in many instances the molecules responsible for activation of NK cells remain undefined, increasing information is emerging about the role of MHC molecules as inhibitory elements in NK/target cell interactions (10) (11) (12) . Attention to MHC involvement in NK regulation first came through the observation that increasing MHC expression on tumor cells induced NK resistance (13, 14) , and transfection of some MHC genes into susceptible tumor cells conferred resistance to NK lysis (15) . For human NK cells, an element of specificity in resistance was revealed with studies of defined HLA-A molecules (16) . Involvement of HLA-C in providing resistance to particular NK cells was shown by conferring protection to susceptible target cells through transfection of the HLA-Cw3 allele (17) . Further work pinpointed a dimorphism in HLA-C localized at positions 77 and 80 of the cxl-helical region that serves as a useful marker for HLA-C alleles capable of inducing resistance to selected NK cells (18) (19) (20) . More recently, resistance to other NK clones was found to be associated with the Bw4 and Bw6 epitopes expressed by defined HLA-B alleles (7, 21, 22) .
The finding that different HLA-A, -B, or -C alleles could provide resistance to particular NK populations suggests that the effector ceils express variable receptor molecules involved in mediating inhibitory signals. Several molecules have been identified on murine and human NK cells that correlate with inhibition by MHC molecules, for example the murine Ly49 molecule (23) , the p58 molecular family (24) , the NKB1 receptor (22) , and the CD94 molecule (25) . Selective MHC inhibition has only been described for NK cells, but several NK-related molecules are also found on some T cells where they seem to be involved in regulating cytolytic activity (26, 27) .
In this study, we compared the role of HLA molecules in conferring target cell resistance to lysis mediated by NK cells and non-MHC-restricted cytotoxic T cell populations. These studies show that MHC molecules that induced resistance to the NK ceils also protected target cells from lysis by these particular non-MHC-restricted T cells. In addition, target cells deficient in peptide transporter genes were still protected if transfected with an appropriate HLA-C allele.
Materials and Methods
Panel Cells and Tramfectants. PBLs of healthy Caucasian donors were HLA typed using local and International Histocompatibility Workshop sera by Dr. R. Wank (University of Munich, Munich, Germany). The HLA types of all effector and target cells are presented in Table 1 . EBV-transformed B-lymphoblastoid cell lines (LCL) 1 were established from PBL in RPMI 1640 medium with 10% FCS, 1% PHA (PHA-m; Difco Laboratories, Detroit, MI), and 50% supematant medium of a 12-d culture of a marmoset cell line, producing the B95.8 strain of virus (American Type Culture Collection, Rockville, MD). Daudi and K562 are hematopoietic tumor lines that lack HLA class I expression; both are well known for their NK susceptibility. All LCL were maintained in RPMI medium with 5% FCS, 2 mM r-glutamine, 1 n~M pymvate, and antibiotics. The HLA mutant cell, C1R, was described previously to express only HLA-Cw4 molecules (Cw*040l) and very low levels of HLA-B35 molecules (B'3503) (28) . The HLA-A, -B, and -C-deficient line L721.221 is hemizygous for chromosome 6, and it carries a deletion of the HLA-A and -B loci in the remaining MHC (29) . The T2 line, kindly provided by I)r. R. Tampe (Max Planck Institute of Biochemistry, Martinsrmd, Germany), represents a hybrid obtained by fusion of L721.174 with the T-LCL CEM (30); T2 has lost both copies of chromosome 6 from CEM but retains the mutant HLA haplotype of L721.174, carrying the HLA alleles A*0201, B'5101, and Cw*0102 (31) , and it has an extensive deletion in the class 1I region. T2 is therefore deficient in all copies of peptide transporter (TAP) genes and defective in peptide transport (32) . It maintains residual expression of HLA-A2 (20-25% of wild-type level) through binding of a restricted set of signal peptides (33) . Only low levels of HLA-B51 are found on T2 (34); due to the lack of specific mAb, no conclusions can be made about HLA-Cwl surface expression.
L721.221, CIR, and T2 were transfected by electroporation with genomic DNA of HLA genes cloned into the eucaryotic expression vector pHEBo and selected by hygromycin B resistance (0.5 rag/nil) (Boehringer Mannheim GmbH, Mannheim, Germany). The HLA-B*2705 gene (35) was kindly provided by Dr. E. Weiss (Institute of Human Genetics, University of Munich, Munich, Germany), and the HLA-Cw*0702 gene (36) was provided by Dr. S. Weissman (Yale University, New Haven, CT). The HLA-B*3501 (37), B'3701 (38) , and Cw'0602 (39) genes have been described previously by this laboratory. T2 cells transfected with HLA-B*3501 were kindly provided by I)r. M. Takiguchi (Institute of Medical Science Tokyo, Tokyo, Japan). Transfectant cell lines are designated as .221-Cw'0702 or T2-Cw*0702, for example.
Cytotoxic Effector Lines. Responding PBL were stimulated for 6 d with irradiated (20 Gy) allogeneic PBL (ratio 1:1) in 50 ml culture flasks in RPMI 1640 medium with 2 mM r-glutamine, 1 mM pyruvate, 100 U/ml penicillin, 100 }xg/ml streptomycin, and 15% heat-inactivated pooled human serum (40) . The effector lines were restimulated every 7-12 d and cultured in mediunl supplemented with 50-500 U/ml human rlL-2 (Proleukin; Cetus, EmeryviUe, CA) and 10% conditioned medium (41) . A panel of sublines, including B.3D, B.3M, B.3N, B.3S, and B.3T, was established by limiting dilution (0.3 cells per well) from a 6-d B.3 culture in the presence of rlL-2 and irradiated feeder cells of donor 3.
Separation of CD3 + and CD56 + Subpopulations. To purify CD3+/CD56 -T cells from CD3-/CD56 § NK cells, direct and indirect separations were performed using immunomagnetic beads (Dynal AS, Oslo, Norway). To deplete residual CD56 + cells from an NK-like T cell population (B.3S), cells were incu1Abbreviations used in this paper: LCL, lymphoblastoid cell line; RCR, relative cytotoxic response; TAP, transporter associated with antigen processing (genes). bated with the CD56-specific mAb NKH-1 (Coulter Corp., Hialeah, FL) diluted 1:5 in PBS/1% FCS for 90 rain on ice. Thereafter, lgGl-coupled immunomagnetic beads (Dynal) were added for 30 min at 4~ the cells binding beads were removed by magnetic adherence, leaving a negative fraction of CD3+/CD56 -cells (B.3S.1). Enrichment of CD56+/CD3 -NK cells was performed by direct depletion of the contaminating CD4 + cells from sublines B.3D and B.3T using CD4-coated immunomagnetic beads (Dynal) incubated for 45 min at 4~ followed by removal through magnetic adherence resulting in lines B.3D.1 and B.3T.1. The CD56 + fraction of line B.3 was positively selected using the NKH-1 mAb and lgGl-coupled immunomagnetic beads (B.3P). All separated populations were tested for expression of surface markers and cytotoxic activity as described below.
Cell-mediated Lympholysis Assay. Cytotoxic activity was determined in a standard 4-h chromium release assay as described (42) . Spontaneous release was determined by incubating target cells in medium alone. Total release was detected by directly counting an aliquot of labeled cells. The percent of lysis was calculated as follows: percent of lysis = (experimental cpm -spontaneous cpm)/(totaI cpm -spontaneous cpm) X 100. All experiments used at least three step titrations of effector cells. Standard linear regression analysis was performed by plotting the percent of specific lysis against the log of the effector cell numbers. To combine data from separate experiments, a percent relative cytotoxic response (RCR) was calculated as follows: percent of RCR = (percent of lysis of experimental target~percent of lysis of reference target) • 100 at a selected E/T ratio, as described earlier (42) .
Cell-mediated Lympholysis Blocking Using mAbs.
To evaluate the involvement of HLA class I, CD3, and CD8 molecules, respectively, in the interaction of effector cells with target cells, the following mAb were added to the standard chromium release assay: the pan-HLA class I-specific mAb W6/32 (ATCC) and the HLA-B-and -C-specific 4E ascites (kindly provided by Dr. S. Y. Yang, Sloan Kettering Institute for Cancer Research, New York, NY) were used in dilutions ranging from 1:10 to 1:600 and were presented in the tables at 1:20. The MT-301 and MT-811 n~lbs were kindly provided as purified Ig by Dr. E. P. Rieber (Instit~t ffir lmmiinologie der Technischen Universit~it, Dresden, Germany) and were used at concentrations of 20, 10, 1, and 0.1 ~g/ ml. Purified mouse myeloma protein MOPC21 was included at the same concentrations as a negative control. Effector cells were preincubated with the (xCD3 and c~CD8 mAbs, and the target cells were preincubated with the HLA class I~pecific mAb for 30 rain at room temperature. Thereafter, the effector or target cells were added, and chromium release was measured 4 h later. 
Results

HLA-C-associated Specificities of NK and Non-MHCrestricted CD3 + T Cell
Populations. An allogeneic MLC, designated as B.3, was established using responding PBL of donor B and irradiated PBL of donor 3. From limiting dilution cultures of B.3, two subtines (B.3D and B.3M) were selected that showed strong lysis of class I negative target cells (Fig. 1 a) , as did uncloned cells of line B.3 ( Fig. 1 b) . Line B.3 and subline B.3M lysed Daudi and K562 cells while Daudi cells were not recognized by subline B.3D in this experiment; however, lysis of >50% was observed using an even lower E/T ratio of B.3D cells in other experiments not shown. In addition, all three effector populations showed significant lysis of some allogeneic LCL, but recognition did not correlate with HLA molecules of donor 3 used for allogeneic stimulation (see Table 1 ).
FACS | analysis using mAbs directed against lymphocyte surface markers revealed that the two sublines were corn- Table 1 . HLA Antigens of Cell Donors posed of different lymphocyte subtypes. The dominant fraction of the B.3D subline was CD3-/CD56 + (93%) (Fig. 2 a-c ) whereas the majority of B.3M cells was CD3 + (97%), with "~ expressing CD56 ( Fig. 2 d-/~. The phenotype of line B.3 revealed a major CD3 + fraction (97%) of which 18% were also CD56 + ( Fig. 2 g-0-No expression of CD16 was detected in these populations. The CD3-/ CD56 § phenotype of subline B.3D prompted us to look for a correlation of its specificity with MHC molecules that govern NK resistance, including HLA-A (16), Bw4/Bw6 (7, 22) , and subtypes of HLA-C, as defined by variations at positions 77 and 80 in the al-helical region (19, 20) . No association was seen with HLA-A or -B, but classification of target cells according to their HLA-C alleles, based on the NK1 and NK2 specificities, correlated well with the pattern oflysis (Table 1) . Thus, target cells expressing two alleles of the Cw2, Cw4, Cw5, and Cw6 group were strongly lysed, while target cells homozygous or heterozy- NK2  NK1  NK1  NK2  NK1  NKI  NK2  NK2  NK1  NKI  NKI  NK2  NK2  NK2  NK2  NK2  NK1  NK1  NK2  NK1  NK2   NK2   NK2  NK2   NK2   NK2  NK2 gous for Cwl, Cw3, or Cw7 alleles were poorly lysed ( Fig.  1 a) . Based on this pattern, the B.3D subline would be classified as having an NK2 specificity according to the criteria of Colonna et al. (19, 20) . The B.3D subline was isolated from an NK1/NK2 heterozygous donor; assignment of HLA-Cw6 (NK2) and Cw7 (NK1) by serological typing was confirmed by cDNA sequencing of both HLA-C alleles (data not shown). Isolation of NK2-specific cells from this donor is in contrast to the findings of Colonna etal., who only isolated NK2-specific cells from NK1 homozygous donors (19, 20) . To our surprise, the CD3+/CD8 + T cell subline B.3M showed a pattern oflysis identical to that of the NK subline (Fig. 1 a) . In addition, cells of the CD3 + line t3.3 cultured for various periods of time mediated ]ysis of allogeneic LCL that correlated with the NK2 group of HLA-C alleles: target cells lacking Cwl, Cw3, or Cw7 expression were more susceptible to lysis than target ceils ex-pressing one of these alleles (Fig. 1 b) . This pattern of specificity emerged as the dominant characteristic of line B.3 after longer cultivation in vitro ( Fig. 1 b, 
Exp. 1 vs Exp. 2).
Combined, these results suggest that the HLA-C specific~ ties associated with inhibition of the NK cells might also explain the lysis pattern of these non-MHC-restricted T cells.
HLA-C Molecules Govern Target Cell Resistance to Lysis by both NK and Non-MHC-restricted T Cells. Two interpre-
tations of the lysis patterns of these NK and T cells could be made: the effector cells may specifically recognize given HLA-C alleles; alternatively, target cells with particular HLA-C alleles may be resistant to lysis. The NK cells and the T cells recognized at least one target cell not known to express HLA-C molecules (Daudi or K562) and allogeneic cells heterozygous for NK1-and NK2-associated alleles were not lysed; these results argued in favor of HLA-C- mediated resistance to lysis. This interpretation was directly supported by a segregation study in family Le (Fig. 3) ; the parents are N K 1 / N K 2 heterozygous ( C w l / C w 6 and C w 4 / C w 7 ) and four children have inherited different combinations o f alleles (Table 1 ). All three effector cell lines preferentially lysed cells of the two children homozygous for NK2 alleles (Cw4/Cw6), while cells of the parents and the other two children were generally resistant, presumably because o f C w l or Cw7 expression. H L A -C w 7 molecules seemed to be somewhat more effective in conferring protection from lysis by line B.3. An influence o f the Bw4 and Bw6 epitopes in this family was excluded since the parents are homozygous for Bw4 or Bw6, respectively. Segregation of individual HLA-B alleles expressing either the Bw4 or Bw6 epitope could not explain the lysis pattern. This study revealed that M H C -l i n k e d susceptibiliv/to lysis by these n o n -M H C -r e s t r i c t e d T cells was recessive, while resistance was dominant, a characteristic described previously for N K cells (11) . In family Le, resistance to lysis showed dominant segregation with HLA haplotypes carrying N K l -r e l a t e d alleles. To demonstrate that dominant resistance could be conferred by H L A -C alone, the LCL C 1 R was transfected with the HLA-Cw*0702 gene. Because of extensive deletions in the M H C , C 1 R only expresses H L A -C w 4 molecules at the cell surface in appreciable amounts. Since the Cw*040l allele is classified in the NK2 group, transfection o f C I R with HLA-Cw*0702 created a N K 1 / N K 2 bet- 
Transfection of Target
% % % % % E/T % RCR* % R C R Inhibition* % 1LCR Inhibition % R C R Inhibition % R C R Inhibition % R C R Inhibition Line B, erozygous cell line, although the levels o f expression of the two alleles were very different (Fig. 4 c) . Nevertheless, the Cw4 expression was sufficient to induce substantial resistance to lysis by an NKl-specific population that was comparable to the resistance of .221-Cw*0602 cells (data not shown). As shown in Fig. 5 , untransfected Cl1< cells were strongly lysed by the N K subline B.3D and the CD3 + line B.3. Expression of the HLA-Cw*0702 gene in C I R led to complete resistance. Thus, H L A -C w 7 expression again conferred resistance to lysis by both the N K and T cells, which was dominant in an N K 1 / N K 2 heterozygous cell, as surmised from the family study.
Highly Enriched C D 3 + T Cell Populations Are Inhibited by H L A -C w 7 in a Manner Analogous to the Purified C D 5 6 + N K Lines and the Polyclonal T Cell Lines.
To demonstrate that enriched CD3 + T cells show the same pattern o f cytotoxicity as CD56 + N K cells, four sublines were depleted of the contaminating subpopulations by immunomagnetic bead separation (Table 3) . Depletion o f C D 3 + cells from two independently generated sublines, B.3T and B.3D, yielded highly enriched CD56 + N K lines with 90% and 98% C D 3 -/ C D 5 6 + cells, respectively (Fig. 6) . The N K lines demonstrated efficient lysis o f K562, C I R , and .221- Subline B.3S was used to obtain highly enriched T cell populations through CD56 depletion; after two rounds of separation, CD56 + cells could no longer be detected in the B.3S.1 subline (Table 3 and Fig. 6 ). Nevertheless, both T cell sublines showed patterns of lysis exactly like those of the CD56 + N K lines: linear regression analysis gave significant r values for the quantitative lysis o f K562, CIlL, and .221-Cw*0602 cells, and strong inhibition was seen with the Cw*0702 transfectants of C 1 R and L721.221. The lyric activity o f both T cell sublines was less than that of the N K cells; ~1 0 -f o l d more cells were needed to achieve equivalent levels of cytotoxicity (compare B.3D.1 and B.3S, Table 3 ). In the absence o f pure clones it is theoretically possible that a contaminating fraction of CD56 + N K cells like those of the B.3D.1 subline, yet accounting for 1% of the cells in subline B.3S, was responsible for the observed cytotoxicity. If this were the case, however, then the level of C l l L lysis mediated by B.3D.1 cells at an E / T ratio of 0.1:1, for example, should equal that of the B.3S line at an E / T ratio of 10:1. Estimation o f the expected lysis for B.3D.1 from the regression line would give a value o f 0, whereas 27% lysis was seen with B.3S at a 10:1 ratio. In fact, the lysis of C l l L by B.3D.1 at 1:1 is equivalent to that seen with B.3S at 10:1, yet only 1%, not 10%, o f the cells had a C D 3 -/ C D 5 6 + phenotype. Therefore, it is highly unlikely that the activity in the T cell sublines was caused by residual C D 3 -/ C D 5 6 + N K cells.
Separation experiments performed to isolate C D 3 + / Fig. 2 g-t) . Some reactivity directed against K562 was observed, but lysis of C1R and .221-Cw*0602 cells was very weak or absent. Since enrichment of CD3+/CD56 + cells required positive selection through the CD56-specific mAb, it may be that the separation procedure led to an alteration in their lytic capacity. Based on the results seen with the B.3S.1 subline, however, CD56 is not a characteristic marker for non-MHC-restricted T cells showing this pattern of specificity.
HLA Class 1-specific Antibodies, but not CD3 or CD8 Antibodies, Can Restore Lysis of Resistant Target Cells.
Blocking experiments were made using various mAb to evaluate the involvement of HLA-class I, CD3, and CD8 molecules in recognition and inhibition oflysis mediated by the NK-like T cells. For these experiments, target cells of two members of family Le used for the segregation study (Fig. 3) were selected since they expressed comparable levels of class I molecules, yet they behaved differently as target cells. The cell TL (Cw4/Cw6) was lysed while the parental ML cells expressed HLA-Cw7 (Cw4/Cw7) and were resistant. For comparison, a CD56 + NK line was included. As a control for the proper functioning of the mAb, a CD3+/CD8 + HLA-B35-specific CTL line was tested against both target cells in the presence of various concentrations ofmAb. The data in Table 4 are representative of three experiments and the values of lysis obtained in the presence of the highest concentration of each mAb used in each combination are given. Both target cells expressed HLA-B35 (Table 1) and were well lysed by line GM. 1. The class I-specific reagents, W6/32 and 4E, inhibited lysis from 42 to 80%; the 4E mAb was more effective. 60-80%, inhibition was observed with the CD3-specific mAb, whereas the CD8 mAb only caused 40% inhibition. In other experiments, half-maximal concentrations of the CD3 and CD8 mAb were used and shown to cause full impairment oflysis of an HLA-A2~pe-cific T cell clone (data not shown). Thus, as expected, all mAb functioned to inhibit E/T interactions involving classical CTL.
Very different patterns of inhibition were seen with the NK-like T cells and the NK subline compared to this clas- 
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sical CTL. No inhibition of the positive lysis of TL cells was seen with any mAb; thus, CD3 and CD8 molecules were not involved in positive recognition by the T cells. As expected, the ML cells caused strong inhibition of both effector cells. This inhibition was retained despite blocking of CD3 and CD8 molecules on the NK-like T cells. Once again, these molecules were not found to be involved in inhibition of lysis. In contrast, the inhibition of cytotoxicity by ML cells was lost when the target cells were preincubated with the class I-specific mAb. This could not be accounted for by antibody-dependent, cell-mediated cytotoxicity since neither population expressed CD16 (data not shown). This dramatic reversal of inhibition demonstrated that a direct interaction with Cw7 molecules was required to inactivate both the NK-like T cells and the NK subline.
Impaired Peptide Loading in T2 Does
Not Influence the Ability of HLA-Cw*0702 to Confer Resistance to Lysis. The dimorphic variations at positions 77 and 80 that characterize the NK1/NK2 groups of HLA-C alleles lie in positions of the ell-helical region, which could influence binding of endogenous peptides. Since T2 cells express no TAP1 and TAP2 genes, they present only a limited spectrum of endogenous peptides (33) . T2 cells were found to be highly sensitive to lysis by both effector cell types (Fig. 5) ; thus the Cw*0102 allele present in this cell may be so poorly ex- pressed that it cannot induce resistance. After transfection with HLA-B*3501, HLA-Cw*0602, or Cw*0702, T2 cells showed shifts in staining with the class I-specific mAb W6/32, revealing substantial surface expression of MHC molecules in all three transfectant lines (Fig. 4 d-J) . T2-B'3501 and T2-Cw*0602 cells remained sensitive to NK and T cell cytotoxicity, but lysis of T2-Cw*0702 cells was abrogated. Thus, impaired peptide loading in T2 did not lead to failure of Cw7 molecules to provide protection to either effector cell type.
An NK2 Specificity Is Exhibited by a Second Non-MHCrestricted T Cell Population.
A second allogeneic effector population (line A.1) was made using PBL of the NK1 homozygous donor A stimulated with PBL of donor 1. FACS | analysis demonstrated that line A.1 was 96% CD3 + but, like line B.3, it contained several T cell subtypes (Fig.  2 j-/) . Line A.1 lysed K562 and Daudi; moreover, target cells expressing Cw2, Cw4, Cw5, or Cw6 were susceptible to lysis while cells expressing Cw7 were clearly resistant (Fig. 7 a) . Segregation analysis in family Le gave the same results as seen with the effector populations of donor B (data not shown). The HLA-Cw*0702 transfectant of L721.221 was resistant to lysis, as were C1R-Cw*0702 cells (Fig. 7 b) . Impaired peptide loading did not strongly influence resistance since T2-Cw*0702 cells conferred 65% 
Discussion
Extensive studies of NK clones revealed comFlex patterns of specificity with respect to involvement of HLA-A, -B, or -C molecules in delivering inhibitory signals (43) , yet numerous NK clones seem not to be susceptible to MHC regulation (5) . The various effector populations described in this study were highly divergent with respect to lymphocyte composition, ranging from a highly enriched (>95%) CD3-/CD56 + subline (B.3D) to the mixed CD4 § CD8 +, and CD56 + phenotypes of the polyclonal CD3 + lines B.3 and A.1 and the clear CD3+/CD8 + phenotype of the T cell subline B.3M. Additional depletion of CD56 + cells yielded the CD3+/CD56 subline B.3S.1 (99% CD3+/CD56-), which showed the same specificity as the CD3-depleted CD56+(99%) subline B.3D.1. It is therefore astonishing that such homogenous patterns of cytolytic specificity were found in these populations that differed 100-fold in their content of CD3 + non-MHC-restricted T cells and CD56 + NK cells.
The clear results obtained using single HLA gene transfectants demonstated that HLA-Cw7 molecules not only conferred resistance to the B.3D NK cells in a manner like that shown for other NK cells with various HLA-C transfectants (17, 19) , but they also protected target cells from lysis by non-MHC-restricted CD3 + populations. Since one target cell with HLA-Cwl (father Le) and one with Cw3 (GN) were not lysed, the NK1 group of HLA-C alleles described by Colonna et al. (20) may detemfine resistance; nevertheless, studies of larger panels of allogeneic LCL and HLA-C transfectant lines will be important to establish the fine specificity of protection. We could block the inhibition of lysis by HLA-Cw7 of an NK line and a non-MHC-restricted T cell line with two HLA class I-specific mAb. Direct binding of the effector cell to the HLA-C molecules expressed by the target cell is therefore necessary to inhibit their lysis. In contrast, lysis of targets lacking a protective HLA-C allele was not influenced by class I~pe-cific mAbs for either effector type. The CD3 and CD8 molecules that are involved in classical CTL lysis appear to be irrelevant for lysis as well as for inhibition since neither Qualitative changes in the conformation of the class I heavy chain-peptide-[32m complex are reported to influence NK resistance, and an increased sensitivity has been observed for some NK cells because of peptide loading to MHC molecules (5, 44, 45) or by addition of [32-microglobulin (46) . It is still unclear whether or not specific peptides may be required to induce resistance, but TAP genes could be involved in NK resistance (34) . Limited peptide specificity in inhibition mediated by HLA-B27 to some NK cells was recently demonstrated (47) , leading to different models for peptide involvement in selective NK recognition (48) . Information with respect to HLA-C-mediated resistance is not yet available, In our studies, the comparison of the TAP-deficient cell line T2 and the related L721.221 cell line, after transfection with Cw*0702, revealed no differences in resistance to NK and T cell lysis. It is not known whether the HLA-C molecules occurring on T2 are devoid of peptides or are occupied with a special subset of endogenous peptides, such as signal peptides like those associated with HLA-A2 (33) . The binding of the mAb W6/32 to the T2 transfectant cells indicates that some HLA-C molecules are associated with [32-microglobulin since the epitope recognized by W6/32 is only displayed when class I heavy chains are associated with [32-microglobulin (49) . At least for HLA-A and -B molecules this association also requires peptide to maintain stable surface expression at 37~ (50). If the same rules govern HLA-C expression, then peptides are likely to be associated with these HLA-C molecules on T2; nevertheless, substantial alterations in their composition, as expected from the TAP deficiency, did not influence protection by Cw7. Perhaps many peptides allow folding and display of Cw7 mol-ecules in a form that confers resistance. On the other hand, it is also possible that Cw7 heavy chains alone provide protection; if so, then such heavy chains must also be present on other transfectant cell lines as well as on normal cells that are resistant to lysis.
Increasing evidence suggests that many viral pathogens and tumor cells use a variety of mechanisms to downregulate MHC expression, thereby escaping detection by MHC-restricted CTL (51) . An important function of NK cells and NK-like T cells could be to serve as sensitive biological densitometers detecting aberrations in MHC expression. Since HLA-C molecules are expressed at substantially lower levels than HLA-A and -B (52), slight differences in expression may alter the inhibitory signal in the effector cells that provides protection from lysis for normal cells. Even minor alterations in HLA-C expression in vivo might trigger the attack of cells harboring such pathogens or carrying mutations affecting MHC expression by effector cells, such as those described here.
Others have shown that the HLA-C specificity of NK clones correlates with expression of various molecules of the p58 family (53, 54) . Direct binding of a defined HLA class I molecule to a given p58 receptor could protect target cells and reversion to lysis was detected in the presence of anti-p58 antibody (55) . Similarly the NKB1 and CD94 (Kp43) molecules, expressed by subsets of NK cells, are receptor candidates involved in NK inactivation by particular HLA-B molecules; such NK cells are not inhibited by HLA-C. Some NK clones that express both CD94 and p58 molecules have been described; they display dual specificity for HLA-B and -C inhibitory signals (25) . Recently, other antibodies directed against p58 molecules were found to bind to both NK cells and a limited subset ofCD8 + T lymphocytes that show non-MHC-restricted lytic activity (26) . The common expression of some surface receptors (26, 27) and overlapping cytotoxic specificities support the contention that some non-MHC-restricted T cells may be related to NK cells in their mode of activation and/or regulation. NK and T cells may also be derived from a common progenitor cell (56, 57) . Our observation that HLACw7-mediated resistance to cytolysis is not only associated with a CD3-NK cell subline but also with a CD3 + T cell subline and polyclonal, non-MHC-restricted T cell populations provides evidence for a regulatory relationship between these different types ofeffector cells. It will be of interest to investigate whether the T cells described here express any molecules of the p58 family that are associated with HLA-C regulation of NK cells.
The frequencies and specificities of the NK and NK-like T cells present in an individual could reflect his pathogen history: intracellular pathogens that downregulate or qualitatively alter MHC expression in a locus-or allele-specific manner could lead to preferential selection of one group of effector cells, while generalized downregulation of MHC molecules might select cells with several different specificities. This could contribute to the wide variations in the numbers of cells binding the anti-p58, NKB1, or CD94 antibodies found in different individuals (22, 24, 25) . If similar molecules are involved in T cell interactions, this might help to explain why distinct specificities could be identified in the two polyclonal T cell lines described here. Alternatively, it has been shown that individual NK clones can express simultaneously different receptor molecules associated with HLA-B-or -C-mediated inhibition (25) . This may not be the case for T cells, thereby limiting their specificities and enabling these to be defined in uncloned T cell lines, while this is not possible with mixed NK populations (5).
